- Zacks•2 days ago
VIVUS, Inc. (VVUS) recently announced an agreement with Sanofi to reacquire the commercial rights to its erectile dysfunction drug, Stendrain Africa, the Middle East, Turkey and the Commonwealth of Independent States, including Russia.
- MarketWatch•3 days ago
Vivus Inc. shares rose 4.6% in premarket trade Monday after the company said it would regain the right to commercialize and promote erectile dysfunction drug Stendra in Africa, the Middle East, Turkey ...
- Marketwired•3 days ago
VIVUS, Inc. , announced today that it reached an agreement with Sanofi to return the commercial rights for STENDRA in Africa, the Middle East, Turkey and the Commonwealth of Independent States, including ...
VVUS : Summary for VIVUS, Inc. - Yahoo Finance
VIVUS, Inc. (VVUS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||1.09 x 8900|
|Ask||1.14 x 1500|
|Day's Range||1.08 - 1.13|
|52 Week Range||0.93 - 1.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||5.05|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|